{
     "PMID": "21615561",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20111219",
     "LR": "20161125",
     "IS": "1460-9568 (Electronic) 0953-816X (Linking)",
     "VI": "34",
     "IP": "1",
     "DP": "2011 Jul",
     "TI": "Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing.",
     "PG": "12-21",
     "LID": "10.1111/j.1460-9568.2011.07719.x [doi]",
     "AB": "Adenosine neuromodulation depends on a balanced activation of inhibitory A(1) (A(1)R) and facilitatory A((2)A) receptors (A((2)A) R). Both A(1) R and A((2)A) R modulate hippocampal glutamate release and NMDA-dependent long-term potentiation (LTP) but ageing affects the density of both A(1) R and A((2)A) R. We tested the effects of selective A(1) R and A(2A) R antagonists in the modulation of synaptic transmission and plasticity in rat hippocampal slices from three age groups (young adults, 2-3 month; middle-aged adults, 6-8 months; aged, 18-20 months). The selective A((2)A) R antagonist SCH58261 (50 nm) attenuated LTP in all age groups, with a larger effect in aged (-63 +/- 7%) than in middle-aged adults (-36 +/- 9%) or young adult rats (-36 +/- 9%). In contrast, the selective A(1) R antagonist DPCPX (50 nm) increased LTP magnitude in young adult rats (+42 +/- 6%), but failed to affect LTP magnitude in the other age groups. Finally, in the continuous presence of DPCPX, SCH58261 caused a significantly larger inhibition of LTP amplitude in aged (-71 +/- 45%) than middle-aged (-28 +/-9%) or young rats (-11 +/- 2%). Accordingly, aged rats displayed an increased expression of A((2)A) R mRNA in the hippocampus and a higher number of glutamatergic nerve terminals equipped with A(2A) R in aged (67 +/- 6%) compared with middle-aged (34 +/- 7%) and young rats (25 +/- 5%). The results show an enhanced A((2)A) R-mediated modulation of LTP in aged rats, in accordance with the age-associated increased expression and density of A((2)A) R in glutamatergic terminals. This age-associated gain of function of A((2)A) R modulating synaptic plasticity may underlie the ability of A((2)A) R antagonists to prevent memory dysfunction in aged animals.",
     "CI": [
          "(c) 2011 The Authors. European Journal of Neuroscience (c) 2011 Federation of",
          "European Neuroscience Societies and Blackwell Publishing Ltd."
     ],
     "FAU": [
          "Costenla, Ana R",
          "Diogenes, Maria J",
          "Canas, Paula M",
          "Rodrigues, Ricardo J",
          "Nogueira, Celia",
          "Maroco, Joao",
          "Agostinho, Paula M",
          "Ribeiro, Joaquim A",
          "Cunha, Rodrigo A",
          "de Mendonca, Alexandre"
     ],
     "AU": [
          "Costenla AR",
          "Diogenes MJ",
          "Canas PM",
          "Rodrigues RJ",
          "Nogueira C",
          "Maroco J",
          "Agostinho PM",
          "Ribeiro JA",
          "Cunha RA",
          "de Mendonca A"
     ],
     "AD": "Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. cunharod@gmail.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20110525",
     "PL": "France",
     "TA": "Eur J Neurosci",
     "JT": "The European journal of neuroscience",
     "JID": "8918110",
     "RN": [
          "0",
          "(5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimi",
          "dine)",
          "0 (Adenosine A1 Receptor Antagonists)",
          "0 (Adenosine A2 Receptor Antagonists)",
          "0 (Pyrimidines)",
          "0 (Receptor, Adenosine A1)",
          "0 (Receptor, Adenosine A2A)",
          "0 (Triazoles)",
          "0 (Xanthines)",
          "3KX376GY7L (Glutamic Acid)",
          "6384-92-5 (N-Methylaspartate)",
          "9PTP4FOI9E (1,3-dipropyl-8-cyclopentylxanthine)",
          "K72T3FS567 (Adenosine)"
     ],
     "SB": "IM",
     "MH": [
          "Adenosine/metabolism",
          "Adenosine A1 Receptor Antagonists/pharmacology",
          "Adenosine A2 Receptor Antagonists/pharmacology",
          "Aging/*physiology",
          "Animals",
          "Electrophysiology",
          "Excitatory Postsynaptic Potentials/drug effects/physiology",
          "Glutamic Acid/metabolism",
          "Hippocampus/drug effects/*physiology",
          "Long-Term Potentiation/drug effects/*physiology",
          "Male",
          "Memory Disorders/physiopathology",
          "N-Methylaspartate/metabolism",
          "Neuronal Plasticity/drug effects/physiology",
          "Pyrimidines/pharmacology",
          "Rats",
          "Rats, Wistar",
          "Receptor, Adenosine A1/*metabolism",
          "Receptor, Adenosine A2A/*metabolism",
          "Synaptic Transmission/drug effects/physiology",
          "Triazoles/pharmacology",
          "Xanthines/pharmacology"
     ],
     "EDAT": "2011/05/28 06:00",
     "MHDA": "2011/12/20 06:00",
     "CRDT": [
          "2011/05/28 06:00"
     ],
     "PHST": [
          "2011/05/28 06:00 [entrez]",
          "2011/05/28 06:00 [pubmed]",
          "2011/12/20 06:00 [medline]"
     ],
     "AID": [
          "10.1111/j.1460-9568.2011.07719.x [doi]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Neurosci. 2011 Jul;34(1):12-21. doi: 10.1111/j.1460-9568.2011.07719.x. Epub 2011 May 25.",
     "term": "hippocampus"
}